首页 › 基金 › Finepoint Capital LP › CLDI
Finepoint Capital LP 对 CLDI 的持仓历史
CALIDI BIOTHERAPEUTICS INC · 医疗保健
Finepoint Capital LP 在 Q3 2026 的 13F 申报中披露持有 CLDI(CALIDI BIOTHERAPEUTICS INC)66 股,市值约 US$0K,约占其申报组合的 0.00%,在其申报持仓中市值排名第 10 位。 Finepoint Capital LP 最近 13 个申报季度中有 13 个季度披露了 CLDI 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Finepoint Capital LP 对 CLDI 的持仓演变
Finepoint Capital LP 于 Q3 2023 首次披露 CLDI 持仓:125,000 股(约 US$416K)。 在 13 次申报中,Finepoint Capital LP 0 次增持、3 次减持、9 次保持不变。 最近一期申报(Q3 2026)显示持股 66 股、市值约 US$0K,环比减持 -976 股。。 持仓曾出现大幅变动:Q3 2024 减持约 90% (随后一个季度股价基本持平)、Q3 2025 减持约 92% (随后一个季度股价下跌 23%)、Q3 2026 减持约 94% (随后一个季度股价下跌 42%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 125.00K | $415.62K | 新进 |
| Q4 2023 | 125.00K | $188.75K | 持有 |
| Q1 2024 | 125.00K | $70.62K | 持有 |
| Q2 2024 | 125.00K | $25.00K | 持有 |
| Q3 2024 | 12.50K | $14.25K | 减持 |
| Q4 2024 | 12.50K | $14.38K | 持有 |
| Q1 2025 | 12.50K | $7.08K | 持有 |
| Q2 2025 | 12.50K | $2.88K | 持有 |
| Q3 2025 | 1.04K | $1.58K | 减持 |
| Q4 2025 | 1.04K | $1.22K | 持有 |
| Q1 2026 | 1.04K | $249 | 持有 |
| Q2 2026 | 1.04K | $177 | 持有 |
| Q3 2026 | 66 | $71 | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CLDI 与 13F 数据
CLDI(CALIDI BIOTHERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 14 只申报持有 CLDI。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 Finepoint Capital LP
常见问题
How long has Finepoint Capital LP held CLDI?
Finepoint Capital LP has disclosed CLDI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Finepoint Capital LP's current position in CLDI?
As of Q3 2026, Finepoint Capital LP holds 66 shares of CLDI (CALIDI BIOTHERAPEUTICS INC), valued at $71, representing 0.00% of its reported portfolio and ranking #10.
Has Finepoint Capital LP been buying or selling CLDI?
In the latest 13F filing (Q3 2026), Finepoint Capital LP reduced its position in CLDI.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.